Vilobelimab

Generic name: Vilobelimab
Brand names: Gohibic
Dosage form: intravenous solution (10 mg/mL)
Drug class: Miscellaneous antivirals

Usage of Vilobelimab

COVID-19 is a serious disease caused by a coronavirus called SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). COVID-19 is spread from person to person through the air.

COVID-19 can affect your lungs or other organs. Symptoms may be mild or serious and include fever, chills, cough, sore throat, shortness of breath, tiredness, body aches, headache, loss of taste or smell, runny or stuffy nose, nausea, vomiting, or diarrhea.

The US Food and Drug Administration (FDA) has authorized emergency use of vilobelimab to treat COVID-19 in hospitalized adults when started within 48 hours of invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO, a heart-lung machine that helps increase oxygen in the blood). vilobelimab has not been approved by the FDA to treat COVID-19.

Vilobelimab may also be used for purposes not listed in this medication guide.

Vilobelimab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Vilobelimab may cause serious side effects. Call your doctor at once if you have:

  • signs of infection--fever, chills, sore throat, body aches, unusual tiredness, loss of appetite, bruising or bleeding.

    • Common side effects of vilobelimab may include:

  • confusion;
  • constipation;
  • rash;
  • irregular heartbeats;
  • pain, swelling, or warmth in one leg;
  • pain and burning when you urinate;
  • chest pain, breathing problems, shortness of breath;
  • severe headache, blurred vision, pounding in your neck or ears;
  • easy bruising, unusual bleeding, purple or red spots under your skin;
  • cold symptoms such as stuffy nose, sneezing, sore throat;
  • symptoms of sepsis--confusion, fever or chills, severe drowsiness, fast heartbeats, rapid breathing, feeling very ill; or
  • symptoms of herpes virus--cold sores around your mouth, skin sores or blisters, itching, tingling, burning pain in your thigh or lower back.

    • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Vilobelimab

    Tell your doctor if you have:

  • allergies;
  • an infection other than COVID-19; or
  • any serious illnesses.

    • Tell your doctor if you are pregnant or plan to become pregnant, or breastfeeding or plan to breastfeed.

    Relate drugs

    How to use Vilobelimab

    Usual Adult Dose for COVID-19:

    For investigational use only800 mg IV for up to 6 doses as follows:-Treatment should be started within 48 hours of intubation (Day 1) followed by administration on Days 2, 4, 8, 15, and 22 as long as the patient is hospitalized (even if discharged from intensive care unit).Comments:-The US FDA issued an Emergency Use Authorization (EUA) to allow the emergency use of vilobelimab for the treatment of coronavirus disease 2019 (COVID-19) in hospitalized patients when initiated within 48 hours of receiving invasive mechanical ventilation (IMV) or extracorporeal membrane oxygenation (ECMO); this drug is not approved by the US FDA for this use.-For additional information: https://www.fda.gov/drugs/emergency-preparedness-drugs/emergency-use-authorizations-drugs-and-non-vaccine-biological-productsUse: For the treatment of COVID-19 in hospitalized patients when initiated within 48 hours of receiving IMV or ECMO

    Warnings

    The US Food and Drug Administration (FDA) has authorized emergency use of vilobelimab to treat COVID-19 in hospitalized adults when started within 48 hours of invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO, a heart-lung machine that helps increase oxygen in the blood). vilobelimab has not been approved by the FDA to treat COVID-19.

    What other drugs will affect Vilobelimab

    Other drugs may affect vilobelimab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords